Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Institution
- Keyword
- Publication
- Publication Type
Articles 1 - 3 of 3
Full-Text Articles in Eye Diseases
Visual Performance, And It's Response To Intervention, In Subjects With Age-Related Macular Degeneration., Sarah Sabour-Pickett
Visual Performance, And It's Response To Intervention, In Subjects With Age-Related Macular Degeneration., Sarah Sabour-Pickett
Doctoral
Abstract Objectives: 1. To explore visual performance status through a range of psychophysical methods beyond corrected distance visual acuity (CDVA), in subjects with age-related macular degeneration (AMD). 2. To investigate the effects on these visual performance parameters in subjects with neovascular age-related macular degeneration (nv-AMD) and in subjects with early AMD undergoing anti-VEGF (vascular endothelial growth factor) therapy and macular carotenoid supplementation, respectively. 3. To understand the role of a supplement containing meso-zeaxanthin (MZ; the third, and currently least explored, macular carotenoid) on the augmentation of macular pigment (MP), on visual performance and on disease progression (graded according to the …
Beta-2-Adrenergic Receptor Regulates Insulin Signaling To Reduce Cell Death In Müller Cells, Robert Jason Walker
Beta-2-Adrenergic Receptor Regulates Insulin Signaling To Reduce Cell Death In Müller Cells, Robert Jason Walker
Theses and Dissertations (ETD)
No abstract provided.
Is Fixed-Combination Prostaglandin Analog/Β-Blocker Therapy Safe And More Effective Than Β-Blocker Monotherapy In The Prevention Of Disease Progression In Adults With Open-Angle Glaucoma?, My-Hang Pham
PCOM Physician Assistant Studies Student Scholarship
Objective: The objective of this selective EBM review is to determine whether fixed-combination prostaglandin analog/β-blocker therapy is safe and more effective than β-blocker monotherapy in the prevention of disease progression in adults with open-angle glaucoma.
Study Design: Review of three English language randomized controlled trials published in 2008 and 2010.
Data sources: 3 randomized, controlled, double-blind trials comparing fixed-combination prostaglandin analog/β-blocker therapy to β-blocker monotherapy were found using Pubmed, Medline, and Cochrane databases.
Outcome Measured: Disease progression/regression was assessed by post-baseline measurement of IOP during three follow-up visits throughout the trials. The safety profile of each therapy was …